+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Finland

  • ID: 4620676
  • Report
  • Region: Finland
  • 140 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Finland

Summary

The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Finland. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Finland. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.

Finland is one of the rapidly emerging markets in the EU, with a strong focus on pharmaceutical R&D. It spends approximately 9.4% of its GDP on healthcare. The pharmaceutical market value decreased from $2.50 billion in 2010 to $2.47 billion in 2015 at negative CAGR of 0.26%, owing to an increase in generic volume from 34% in 2010 to 42% in 2015. It is expected to reach $2.65 billion in 2022. However, the market value in terms of Euros was €1.89 billion in 2010 and increased at a CAGR of 3% from 2015. It is expected to reach €2.80 billion in 2022. The Finnish medical device market was valued at $0.99 billion in 2010, which increased to $1.27 billion in 2017. The main segments were cardiovascular devices, diabetes care devices, in vitro diagnostics, orthopedic devices and ophthalmic devices. The increasing elderly population, favorable foreign investment environment and tremendous innovation are expected to drive the growth of the pharmaceutical market. However, generic substitution, increased healthcare expenditure and presence of counterfeit medicines act as a major barrier for the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Finland, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, GSK, Sanofi and Orion) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche, DePuy, Zimmer Biomet and Revenio)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Finland
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Finland
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Finnish healthcare market.
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Finnish healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Finnish healthcare market.
Note: Product cover images may vary from those shown
2 of 2
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2016
Table 2: Pharmaceutical Market, Finland, Sales of Major Drug Categories by Major Therapeutic Class ($m), 2016
Table 3: Medical Device Market, Finland, Revenue by Segment
Table 4: Cardiovascular Devices Market, Finland, Revenue and Market Share of Major Players
Table 5: Diabetes Care Devices Market, Finland, Revenue and Market Share of Major Players
Table 6: In Vitro Diagnostics Devices Market, Finland, Revenue and Market Share of Major Players
Table 7: Orthopedic Devices Market, Finland, Revenue and Market Share of Major Players
Table 8: Ophthalmic Devices Market, Finland, Revenue and Market Share of Major Players
Table 9: Reimbursement for Medical Expenses, Finland
Table 10: Exceptional Copayment Rate for Specific Medicines, Finland
Table 11: Market Authorization Fees, 2017, Finland
Table 12: Patent Fees, 2017, Finland
Table 13: Pharmacy Tax for a Pharmacy Owning a Subsidiary Pharmacy
Table 14: Package Label Information, Finland, 2017
Table 15: Trade Associations, Finland
Table 16: Trade Fairs, Finland

List of Figures
Figure 1: Pharmaceutical Market, Finland, Revenue, 2010-2017
Figure 2: Medical Device Market, Finland, Revenue, 2010-2017
Figure 3: Total Generics Sales (by value), Finland, (%), 2015
Figure 4: Number of Deals (2017-2018)
Figure 5: 2017-2018 Deal Overview By Region
Figure 6: Country Profile, Finland, 2018
Figure 7: Pharmaceutical Market, Finland, Revenue, 2010-2017
Figure 8: Pharmaceutical Market, Finland, Revenue Forecast, 2018-2022
Figure 9: Pharmaceutical Market, Finland, Pharmaceutical Exports
Figure 10: Pharmaceutical Market, Finland, Top Export Partners
Figure 11: Pharmaceutical Market, Finland, Pharmaceutical Imports
Figure 12: Pharmaceutical Market, Finland, Top Import Partners
Figure 13: Pharmaceutical Market, Finland, Supply Channels
Figure 14: Pharmaceutical Market, Finland, Supply Channels, Pharmacies
Figure 15: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class, 2016
Figure 16: Pharmaceutical Market, Finland, Major Players
Figure 17: Medical Device Market, Finland, Revenue, 2010-2017
Figure 18: Medical Device Market, Finland, Revenue Forecast, 2018-2022
Figure 19: Medical Device Market, Finland, Revenue by Segment, 2017
Figure 20: Cardiovascular Market, Finland, Revenue
Figure 21: Cardiovascular Market, Finland, Market Share of Major Players
Figure 22: Diabetes Care Devices Market, Finland, Revenue
Figure 23: Diabetes Care Devices Market, Finland, Market Share of Major Players
Figure 24: In Vitro Diagnostics Devices Market, Finland, Revenue
Figure 25: In Vitro Diagnostics Devices Market, Finland, Market Share of Major Players
Figure 26: Orthopedic Devices, Finland, Revenue
Figure 27: Orthopedic Devices, Finland, Market Share of Major Players
Figure 28: Ophthalmic Devices Market, Finland, Revenue
Figure 29: Ophthalmic Devices Market, Finland, Market Share of Major Players
Figure 30: Diagnostic Market, Finland, Revenue ($bn), 2010-2017
Figure 31: Diagnostic Market, Finland, Revenue Forecast ($bn), 2018-2022
Figure 32: Medical Device Market, Finland, Revenue of Major Players
Figure 33: Deal Value and Deal Count, Pharmaceutical Market, Finland, 2017-2018
Figure 34: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Finland, 2017
Figure 35: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Finland, 2017-2018
Figure 36: Top Five Therapy Area by Deal Value, Pharmaceutical Market, Finland, 2017-2018
Figure 37: Top Five Therapy Area by Deal number, Pharmaceutical Market, Finland, 2017-2018
Figure 38: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Finland, 2017-2018
Figure 39: Medical Device Market Deals, Finland, 2017-2018 (by deal value, $m)
Figure 40: Medical Device Market Deals, Finland, 2017-2018 (by deal count)
Figure 41: Medical Device Market Deals Share (by deal count), Finland, 2017-2018
Figure 42: Medical Device Market Deals Share (by deal value), Finland, 2017-2018
Figure 43: Top Therapy Area by Deal Value, Medical Device, Finland, 2017-2018
Figure 44: Top Therapy Area by Deal Number, Medical Device, Finland, 2017-2018
Figure 45: M&A Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number)
Figure 46: Venture Financing Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number)
Figure 47: Private Equity Deals by Therapy Area, Medical Device Finland, 2017-2018 (by value and by number)
Figure 48: Healthcare System, Finland
Figure 49: Reimbursement Process, Finland
Figure 50: Medical Reimbursement System, Finland
Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health)
Figure 52: Annual Rate of Change (%), Health Price Index, Finland
Figure 53: FIMEA, Organizational Structure, Finland
Figure 54: Life Cycle of Outpatient Medicine, Finland
Figure 55: Centralized Procedure, 2017, Finland
Figure 56: Decentralized Procedure, 2017, Finland
Figure 57: Mutual Recognition Procedure, 2017, Finland
Figure 58: Life Cycle of Medical Devices, Finland
Figure 59: Conformity Assessment of Class I Medical Devices, EU, 2017
Figure 60: Conformity Assessment of Class IIa Medical Devices, EU, 2017
Figure 61: Conformity Assessment of Class IIb Medical Devices, EU, 2017
Figure 62: Conformity Assessment of Class III Medical Devices, EU, 2017
Figure 63: European Patent Approval Process, EU, 2017
Figure 64: Unitary Patent Approval Process, EU, 2017
Figure 65: Trademark Approval Process, Finland, 2018
Figure 66: Number of Hospitals, Finland, 2010-2017
Figure 67: Diagnostic Equipment, Finland, 2010-2017
Figure 68: Hospital Beds (per 1,000 population), Finland
Figure 69: Acute Care Hospital Beds (per 1,000 population), Finland
Figure 70: Psychiatric Hospital Beds (per 1,000 population), Finland
Figure 71: Life Expectancy, 2010-2017, Finland
Figure 72: Immunization Rate (%), 2010-2017, Finland
Figure 73: PM2.5 (μg per m3), Finland, 2010-2016
Figure 74: CO Emissions (million tons), Finland, 2010-2016
Figure 75: Physicians (per 1,000 population), Finland, 2010-2016
Figure 76: Nurses (per 1,000 population), Finland, 2010-2016
Figure 77: Dentists (per 1,000 population), Finland, 2010-2016
Figure 78: Pharmacists (per 1,000 population), Finland, 2010-2016
Figure79: Major Causes of Mortality (per 100,000 population), Finland, 2015
Figure 80: Major Causes of Male Mortality, Finland, 2015
Figure 81: Major Causes of Female Mortality, Finland, 2015
Figure 82: Disability-Adjusted Life Years by Major Disease (‘000), Finland, 2016
Figure 83: Healthcare Expenditure as Percentage of GDP (%), Finland, 2010-2017
Figure 84: Public-Private Share (%), Finland, 2010-2016
Figure 85: Major Components of Healthcare Spending (%), Finland, 2016
Figure 86: Opportunities and Challenges, Finland
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Order Online - visit: https://www.researchandmarkets.com/reports/4620676
Adroll
adroll